Eledon Pharmaceuticals Inc
F:2TK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eledon Pharmaceuticals Inc
F:2TK
|
US |
|
C
|
Chesnara PLC
F:6DE
|
UK |
|
C
|
Cerus Corp
SWB:CU2
|
US |
|
Bluechiip Ltd
F:1BL
|
AU |
|
B
|
Beach Energy Ltd
F:BPS
|
AU |
|
C
|
Cara Therapeutics Inc
F:69C
|
US |
Shareholder Yield
Current shareholder yield for 
2TK is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
2TK Price
Eledon Pharmaceuticals Inc
| Average Annual Return | 11.7% |
| Standard Deviation of Annual Returns | 89.51% |
| Max Drawdown | -85% |
| Market Capitalization | 271.5m EUR |
| Shares Outstanding | 38 510 000 |
| Percentage of Shares Shorted |
N/A
|
2TK Return Decomposition
Main factors of price return
Stock Splits
2TK's latest stock split occurred on Oct 5, 2020
The company executed a 1-for-18 stock split, meaning that for every 18 shares held, investors received 1 new share.
Before the split, 2TK traded at 14.3099 per share. Afterward, the share price was about 14.31.
The adjusted shares began trading on Oct 5, 2020. This was stock split number 2 in 2TK's history, following the previous one in May 11, 2017.
